Creating a New Standard of Care for HF Management
Heart failure (HF) is a major cause of hospitalizations around the world. Approximately 26 million people worldwide live with heart failure.10 In the United Kingdom, 1.3% of the population lives with HF.10 In France, it is 2.2%.10 And in Germany, 141,000 people over the age of 80 live with HF.11 In most areas of the world, heart failure is common and increasing.12
Addressing patients’ needs earlier can mean potentially preventing worsening HF and hospitalization. Abbott offers innovative solutions for electrophysiologists, cardiologists and cardiac surgeons, including, first-to-market quadripolar cardiac resynchronization therapy products with MultiPoint™ pacing technology, market-leading LVADs and our revolutionary acute circulatory assist system. Our focus is comprehensive outcome-driven solutions and integrated technologies, so you can better address your patient and hospital needs.